Biofina Diagnostics S.L has recently attended the 111th American Urological Association’s Annual Meeting (AUA2016) held in San Diego, California, from the 6th until the 10th of May.
Biofina Diagnostics S.L has recently attended the 111th American Urological Association’s Annual Meeting (AUA2016) held in San Diego, California, from the 6th until the 10th of May. Dr. Mengual has presented a poster titled “Prospective, blinded, international and multicenter validation of a gene expression test for the non-invasive diagnosis of bladder cancer”. This poster includes performance results of […]
Press release – Biofina Diagnostics announces two patents were granted in the U.S. and in Canada, from family “BLADDER CANCER DIAGNOSIS AND/OR PROGNOSIS METHOD”
Biofina Diagnostics announces that two new patents have been granted in 2015 in the United States and in Canada, both belonging to the patent family “BLADDER CANCER DIAGNOSIS AND/OR PROGNOSIS METHOD”.In the United States the patent 9,097,715 has been granted by the United States Patent and Trademark Office (USPTO). The Patent Term Adjustment determined by […]
Press release – Biofina Diagnostics S.L will be attending the 111th American Urological Association’s Annual Meeting to be held in San Diego, California, from the 6th until the 10th of May.
Biofina Diagnostics S.L will be attending the 111th American Urological Association’s Annual Meeting to be held in San Diego, California, from the 6th until the 10th of May. Dr. Mengual will present a poster titled “Prospective, blinded, international and multicenter validation of a gene expression test for the non-invasive diagnosis of bladder cancer”. This poster […]
7th European Multidisciplinary Meeting
Dra. Mª José Ribal speaks about bladder cancer biomarkers in the 7th European Multidisciplinary Meeting on Urological Cancers (EMUC) in Barcelona
Press release – Biofina Diagnostics S.L has been awarded with a Seal of Excellence by the European Commission
Biofina Diagnostics S.L has been awarded with a Seal of Excellence by the European Commission following the presentation of its project proposal UROBEST ´UROthelial carcinoma Biomarker based diagnostic tEST´ Submitted under the Horizon 2020’s SME instrument phase 2 call H2020-SMEInst-2014-2015 (H2020-SMEINST-2-2015) of 25 November 2015 in the area of Clinical research for the validation of […]
First level professional in the urologist practice
Dr. Alcaraz and Dra. Ribal are included in the Top Doctors portal (www.topdoctors.es), a tool to find the top-tier Specialists in each medical discipline. Both are included as first level professional in the urologist practice, in particular bladder cancer management. http://www.topdoctors.es/doctor/antonio-alcaraz-asensio http://www.topdoctors.es/doctor/maria-jose-ribal-caparros
The analysis of urine non-invasive diagnosis
Genomic aproaches to the analysis of urine non-invasive diagnosis appear to be approaching the sensitivities and specificities required to be viable alternatives to flexible cystoscopy.
2015 European Association of Urology meeting
The Urology team from the Hospital Clinic of Barcelona, led by Dr. Antonio Alcaraz, presented the poster “Clinical validation of a gene expression test for the non-invasive diagnosis of bladder cancer: A prospective, blinded, international and multicenter study” in the 2015 European Association of Urology meeting.